Data as of Apr 17
| -0.32 / -0.94%|
The 14 analysts offering 12-month price forecasts for Thoratec Corp have a median target of 44.50, with a high estimate of 49.00 and a low estimate of 37.00. The median estimate represents a +32.44% increase from the last price of 33.60.
The current consensus among 16 polled investment analysts is to Buy stock in Thoratec Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.